These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9810944)

  • 1. Neuropsychiatric features of corticobasal degeneration.
    Litvan I; Cummings JL; Mega M
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):717-21. PubMed ID: 9810944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral abnormalities in progressive supranuclear palsy.
    Gerstenecker A; Duff K; Mast B; Litvan I;
    Psychiatry Res; 2013 Dec; 210(3):1205-10. PubMed ID: 24035530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric aspects of progressive supranuclear palsy.
    Litvan I; Mega MS; Cummings JL; Fairbanks L
    Neurology; 1996 Nov; 47(5):1184-9. PubMed ID: 8909427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy.
    Kertesz A; McMonagle P
    J Neurol Sci; 2010 Feb; 289(1-2):138-43. PubMed ID: 19733862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric disturbances in atypical parkinsonian disorders.
    Belvisi D; Berardelli I; Suppa A; Fabbrini A; Pasquini M; Pompili M; Fabbrini G
    Neuropsychiatr Dis Treat; 2018; 14():2643-2656. PubMed ID: 30349262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric assessment of Gilles de la Tourette patients: comparative study with other hyperkinetic and hypokinetic movement disorders.
    Kulisevsky J; Litvan I; Berthier ML; Pascual-Sedano B; Paulsen JS; Cummings JL
    Mov Disord; 2001 Nov; 16(6):1098-104. PubMed ID: 11748741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
    Fabbrini G; Fabbrini A; Suppa A
    Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropsychological comparison between corticobasal degeneration and progressive supranuclear palsy].
    Shibuya N; Tachibana H; Okuda B; Sugita M
    Nihon Ronen Igakkai Zasshi; 2000 Jul; 37(7):541-7. PubMed ID: 11031827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Pillon B; Blin J; Vidailhet M; Deweer B; Sirigu A; Dubois B; Agid Y
    Neurology; 1995 Aug; 45(8):1477-83. PubMed ID: 7644044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Neuropsychology (Broadly Conceived) of Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.
    Gerstenecker A
    Arch Clin Neuropsychol; 2017 Nov; 32(7):861-875. PubMed ID: 28961692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limb apraxia in corticobasal degeneration and progressive supranuclear palsy.
    Soliveri P; Piacentini S; Girotti F
    Neurology; 2005 Feb; 64(3):448-53. PubMed ID: 15699373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy.
    Ječmenica-Lukić M; Pekmezović T; Petrović IN; Tomić A; Svetel M; Kostić VS
    J Neuropsychiatry Clin Neurosci; 2018; 30(1):38-44. PubMed ID: 28506191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders.
    Litvan I; Paulsen JS; Mega MS; Cummings JL
    Arch Neurol; 1998 Oct; 55(10):1313-9. PubMed ID: 9779658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatry of corticobasal degeneration and progressive supranuclear palsy.
    Bruns MB; Josephs KA
    Int Rev Psychiatry; 2013 Apr; 25(2):197-209. PubMed ID: 23611349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders.
    Rittman T; Ghosh BC; McColgan P; Breen DP; Evans J; Williams-Gray CH; Barker RA; Rowe JB
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):544-51. PubMed ID: 23303961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.